1. Home
  2. GYRE vs CARS Comparison

GYRE vs CARS Comparison

Compare GYRE & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

N/A

Current Price

$4.30

Market Cap

625.6M

Sector

Health Care

ML Signal

N/A

Logo Cars.com Inc.

CARS

Cars.com Inc.

N/A

Current Price

$12.33

Market Cap

546.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
GYRE
CARS
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
625.6M
546.6M
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
GYRE
CARS
Price
$4.30
$12.33
Analyst Decision
Strong Buy
Hold
Analyst Count
3
7
Target Price
★ $18.67
$14.36
AVG Volume (30 Days)
210.5K
★ 880.5K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.62
Revenue
$275,000.00
★ $723,239,000.00
Revenue This Year
N/A
$0.41
Revenue Next Year
$27.49
$2.23
P/E Ratio
★ N/A
$19.92
Revenue Growth
N/A
★ 0.57
52 Week Low
$3.97
$7.40
52 Week High
$9.14
$14.02

Technical Indicators

Market Signals
Indicator
GYRE
CARS
Relative Strength Index (RSI) 37.59 52.31
Support Level $3.97 $10.71
Resistance Level $7.28 $12.61
Average True Range (ATR) 0.37 0.66
MACD 0.04 -0.10
Stochastic Oscillator 37.35 32.23

Price Performance

Historical Comparison
GYRE
CARS

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

About CARS Cars.com Inc.

Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.

Share on Social Networks: